Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP351785.RABD3_5IY6BI3XbxrNXd4SAaL7fCKRAvgz6D_488dv-GM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP351785.RABD3_5IY6BI3XbxrNXd4SAaL7fCKRAvgz6D_488dv-GM130_assertion type Assertion NP351785.RABD3_5IY6BI3XbxrNXd4SAaL7fCKRAvgz6D_488dv-GM130_head.
- NP351785.RABD3_5IY6BI3XbxrNXd4SAaL7fCKRAvgz6D_488dv-GM130_assertion description "[Initially, during the primary tumor growth CHL1 could act as a putative tumor suppressor and is silenced to facilitate in situ tumor growth for 11 cancer types.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP351785.RABD3_5IY6BI3XbxrNXd4SAaL7fCKRAvgz6D_488dv-GM130_provenance.
- NP351785.RABD3_5IY6BI3XbxrNXd4SAaL7fCKRAvgz6D_488dv-GM130_assertion evidence source_evidence_literature NP351785.RABD3_5IY6BI3XbxrNXd4SAaL7fCKRAvgz6D_488dv-GM130_provenance.
- NP351785.RABD3_5IY6BI3XbxrNXd4SAaL7fCKRAvgz6D_488dv-GM130_assertion SIO_000772 21408220 NP351785.RABD3_5IY6BI3XbxrNXd4SAaL7fCKRAvgz6D_488dv-GM130_provenance.
- NP351785.RABD3_5IY6BI3XbxrNXd4SAaL7fCKRAvgz6D_488dv-GM130_assertion wasDerivedFrom befree-20150227 NP351785.RABD3_5IY6BI3XbxrNXd4SAaL7fCKRAvgz6D_488dv-GM130_provenance.
- NP351785.RABD3_5IY6BI3XbxrNXd4SAaL7fCKRAvgz6D_488dv-GM130_assertion wasGeneratedBy ECO_0000203 NP351785.RABD3_5IY6BI3XbxrNXd4SAaL7fCKRAvgz6D_488dv-GM130_provenance.